A different randomized trial of exenatide (a GLP-1RA sold as Byetta or Bydureon) in Parkinsons patients also showed benefit, and the effects persisted even after a washout period following treatment
The glucagon component appears to turn up energy expenditure, which is the mechanistic reason its weight-loss numbers ran higher than single and dual agonists in clinical testing
However, additional clinical trials are necessary to prove its effectiveness
Tan SY, Feng X, Cheng LKW, Wu AR
Abstract Glucagon-like peptide-1 receptor (GLP-1R) is a class B G protein-coupled receptor that plays an important role in glucose homeostasis and treatment of type 2 diabetes
Systemic inflammation models: Beyond the gut and skin, KPV has been studied in broader inflammatory models including peritonitis, where it reduced immune cell accumulation and inflammatory markers through mechanisms independent of melanocortin receptors